European Atherosclerosis Society screening recommendations for lipoprotein(a) and high-sensitivity C-reactive protein: double standard or failure of evidence-based medicine?
Goldhaber
Samuel Z
SZ
Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA. sgoldhaber@partners.org
D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis*; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D019317:Evidence-Based Medicine; D006801:Humans; D017270:Lipoprotein(a) / Q000097:blood* / Q000235:genetics; D008403:Mass Screening; D011110:Polymorphism, Genetic; D017410:Practice Guidelines as Topic; D012306:Risk
D015415:Biomarkers; D017270:Lipoprotein(a); D002097:C-Reactive Protein